NeuroOne Medical Technologies Corporation (NMTC) Ownership
NMTC ownership summary
as of October 18, 2026- Institutions
- 22.5% of shares outstanding
- Insiders
- 25.44% of shares outstanding
- Shares outstanding
- 9.1M
- Float
- 6.3M shares available to trade
- Short interest
- 2.03% 179K shares short
- Days to cover
- 1.27 short interest up 135.8% vs prior month
- Institutions 22.45%
- Insiders 25.44%
- Other investors 52.10%
NMTC top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Bleichroeder LP | 7.32% | 667K | $640,666 | −14 (−0.0%) | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 3.87% | 353K | $339,016 | +119,881 (+51.5%) | June 30, 2026 |
| 3 | Bard Associates Inc | 3.35% | 305K | $293,516 | −1,328 (−0.4%) | June 30, 2026 |
| 4 | Perkins Capital Management Inc | 2.69% | 245K | $235,114 | +244,656 (0.0%) | June 30, 2026 |
| 5 | Geode Capital Management, LLC | 1.03% | 94K | $89,906 | −9,048 (−8.8%) | June 30, 2026 |
| 6 | Sio Capital Management, LLC | 0.91% | 83K | $79,539 | −4 (−0.0%) | June 30, 2026 |
| 7 | Renaissance Technologies Corp | 0.78% | 71K | $68,097 | −38,382 (−35.1%) | June 30, 2026 |
| 8 | CAMBRIDGE Invest RESEARCH ADVISORS, INC. | 0.63% | 57K | $54,775 | +28,497 (+100.0%) | June 30, 2026 |
| 9 | Vanguard Fiduciary Trust Co | 0.54% | 49K | $47,106 | +337 (+0.7%) | June 30, 2026 |
| 10 | Essex Investment Management Company, LLC | 0.48% | 44K | $41,878 | −82 (−0.2%) | June 30, 2026 |
| 11 | BlackRock Inc | 0.28% | 25K | $24,141 | +25,121 (0.0%) | June 30, 2026 |
| 12 | Northern Trust Corp | 0.23% | 21K | $20,563 | +2,710 (+14.5%) | June 30, 2026 |
| 13 | Citadel Advisors Llc | 0.17% | 15K | $14,446 | +15,032 (0.0%) | June 30, 2026 |
| 14 | Susquehanna International Group, LLP | 0.15% | 14K | $12,993 | +13,520 (0.0%) | June 30, 2026 |
| 15 | Belpointe Asset Management LLC | 0.14% | 12K | $12,012 | — | June 30, 2026 |
| 16 | Legato Capital Management LLC | 0.11% | 10K | $9,872 | −1 (−0.0%) | June 30, 2026 |
| 17 | UBS Group AG | 0.03% | 2,623 | $2,521 | +2,605 (+14,472.2%) | June 30, 2026 |
| 18 | Morgan Stanley - Brokerage Accounts | 0.02% | 2,058 | $1,978 | +42 (+2.1%) | June 30, 2026 |
| 19 | Northwestern Mutual Wealth Management Co | <0.01% | 361 | $347 | +361 (0.0%) | June 30, 2026 |
| 20 | Wells Fargo & Co | <0.01% | 166 | $160 | −1 (−0.6%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 453K shares and 8 cut 49K.
NMTC top mutual fund and ETF holders
8 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.80% | 255K | $244,995 | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.49% | 45K | $43,057 | −241 (−0.5%) | August 31, 2026 |
| 3 | iShares Micro-Cap ETF | 0.25% | 23K | $21,671 | −156 (−0.7%) | September 30, 2026 |
| 4 | Fidelity Total Market Index | 0.15% | 14K | $13,371 | — | August 31, 2026 |
| 5 | Fidelity Series Total Market Index | 0.13% | 12K | $11,416 | — | August 31, 2026 |
| 6 | Vanguard Balanced Index Inv | 0.08% | 7,716 | $7,415 | — | August 31, 2026 |
| 7 | Fidelity Nasdaq Composite Index | 0.05% | 4,663 | $4,481 | — | August 31, 2026 |
| 8 | 1290 VT Micro Cap K | 0.02% | 1,479 | $1,421 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
NMTC insider transactions
latest 8| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-13 | Mark Christianson | Sell | $4.80 | 16 | $77 |
| 2026-03-12 | Mark Christianson | Sell | $4.80 | 136 | $653 |
| 2026-03-11 | Mark Christianson | Sell | $4.80 | 351 | $1,685 |
| 2026-03-10 | Mark Christianson | Sell | $4.80 | 1,935 | $9,288 |
| 2026-03-01 | David J Wambeke | Buy | $4.02 | 166,666 | $669,997 |
| 2025-09-05 | Mark Christianson | Sell | $4.44 | 5,000 | $22,200 |
| 2025-05-22 | Mark Christianson | Sell | $3.72 | 1,494 | $5,558 |
| 2025-05-21 | Mark Christianson | Sell | $3.90 | 2 | $8 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
NMTC shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns NMTC
Institutional investors own 22.5% of NeuroOne Medical Technologies's shares and insiders 25.44%. The largest holder is Bleichroeder LP with 7.32% of the shares (667K), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 8 reduced their stake in the latest filings. Short interest is 2.03% of the float, or 1.27 days of average trading volume. The share count rose 65.4% since 2014.
Related: NMTC analyst forecast, NMTC key metrics. See the NMTC stock overview for the latest quote and news.
NMTC ownership FAQ
Who owns the most NeuroOne Medical Technologies stock?
The largest shareholders of NeuroOne Medical Technologies are Bleichroeder LP (7.32%), Vanguard Capital Management, LLC (3.87%), Bard Associates Inc (3.35%), Perkins Capital Management Inc (2.69%), Geode Capital Management, LLC (1.03%).
What percentage of NeuroOne Medical Technologies is owned by institutions?
Institutions hold 22.5% of NeuroOne Medical Technologies's shares outstanding; insiders hold 25.44%.
Which funds own NeuroOne Medical Technologies?
The largest fund holders of NeuroOne Medical Technologies are Vanguard MStar Total Stk Mkt Idx Invest (2.80%), Fidelity Extended Market Index (0.49%), iShares Micro-Cap ETF (0.25%), Fidelity Total Market Index (0.15%), Fidelity Series Total Market Index (0.13%).
What is NeuroOne Medical Technologies's short interest?
179K shares of NeuroOne Medical Technologies were sold short, 2.03% of the float; at the average daily volume it would take 1.27 days to cover.
Are insiders buying or selling NeuroOne Medical Technologies?
Of the latest 8 reported insider transactions in NeuroOne Medical Technologies (since May 21, 2025), 1 were purchases and 7 were sales.
How many shares of NeuroOne Medical Technologies are outstanding?
NeuroOne Medical Technologies has 9.1M shares outstanding, of which 6.3M are in the public float.